NanoViricides Inc. (NNVC)

[Rawnoc]

American association of pharmaceutical scientists

"only a relatively small number of nanoparticle-based medicines have been approved for clinical use, with numerous challenges and hurdles at different stages of development"

"The complexity of nanoparticles as multi-component three dimensional constructs requires careful design and engineering, detailed orthogonal analysis methods, and reproducible scale-up and manufacturing process to achieve a consistent product with the intended physicochemical characteristics, biological behaviors, and pharmacological profiles"

"Although small-scale processes may achieve reproducibility with well characterized components, once beyond the early prototype, the reproducibility and consistency of the constructs remain a constant challenge for the scale-up and manufacturing process."

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326161/